Espresso Shot of the Day - SUN PHARMA ADVANCED RESEARCH COMPANY LTD up by 9.87 percent

EspressoLogy

Espresso Shot of the Day - SUN PHARMA ADVANCED RESEARCH COMPANY LTD up by 9.87 percent

January 07, 2022
Espresso Shot of the Day - SUN PHARMA ADVANCED RESEARCH COMPANY LTD up by 9.87 percent

SUN PHARMA ADVANCED RESEARCH COMPANY LTD 324.90  (+9.87%) BSE – INE232I01014 | Jan 7, 2022


Sun Pharma Advanced Research Company (SPARC) is a clinical stage bio-pharmaceutical company focused on continuously improving standards of care for patients globally, through innovation in therapeutics and delivery. SPARC was formed in 2007 through a demerger from SUN PHARMA, a global leader in specialty generics. The company strives to build an enduring innovation engine built on strong scientific execution, high value analytics and aggressive portfolio management. A robust mix of internal ideation and strategic partnering with academic innovators and bio-pharma entrepreneurs fuel their engine with potentially high impact ideas. They partner with thought-leading clinicians across the world for ideas and access. Innovation through integration of partner knowledge and efficient internal execution shapes their future. Their aim is to consistently lower costs and improve operational efficiencies to advance availability and affordability of cures for patients across the world. They realize their dream when they help patients lead more fulfilling lives.

Recent Drivers

  • On Dec 27, 2021, SPARC entered into a licensing agreement with Biomodifying to acquire exclusive rights for producing antibody against unique oncology target.
  • On Nov 9, 2021, the company reported Net Sales of Rs.27.87 crore in September 2021, up 57.99% from Rs.17.64 crores in September 2020.
  • On Dec 8, 2021, the company announced that it has entered into an agreement with Visiox Pharma to grant exclusive worldwide rights for the development and commercialization of PDP-716 and SDN-03.
  • On Dec 8, 2021, SPARC became eligible to receive an upfront payment, milestone payments and royalty on sales, in addition to 10% equity in Visiox.
(Sources: Business Standard, Moneycontrol)


Technical Force*

  • S&P BSE 500 month till date gain up by 2.37%
  • Traded on 52 Week high value 333.75
  • 3 months avg. NSE volume: 683,968
  • Quantity traded: 4, 50,480 | Deliverable quantity: 1, 19,918 (26.62%)
  • Stock price has jumped more than 135% from one-year-low level: 141.00 (Mar 31, 2021)
  • Daily RSI (14) is in Overbought territory today
  • 52-week-high: 333.75 | 52-week-low: 141.00


Key Pivot  (Yearly)

R4

R3

R2

R1

PP /FIB PP

S1

S2

S3

S4

Pivot Point

-

522.83

417.37

351.93

246.47

181.03

75.57

10.13

    -

Fibonacci Pivot

417.37

352.08

311.75

285.77

246.47

207.16

181.18

140.85

75.57


Today’s Close

324.90

SMA

BSE

10 DAY

285.98

20 DAY

272.57

50 DAY

264.70

200 DAY

247.92


Some Key Ratios (Source: BSE)

Market Cap:  8558.85 Crores

PE: -32.34

OPM%: -176.50

ROE%: -5102.75

Promoters holding%: 68.10

Prev. Close: 295.70




*Chart and Technical Force data from the Binge desktop app
The scope and usability of this information/data is time-sensitive and market-based, and as such the same may become outdated for the investment decisions of clients, for which Sharekhan Comtrade bears no responsibility. References to securities do not constitute a recommendation to buy, sell or hold such securities. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document and should consult his own advisors to determine the merits and risks of such an investment. Sharekhan Comrade Private Limited is under no obligation to update the information in this document from time-to-time.


Chandresh Khona
by Chandresh Khona

Product Offerings Head

A teacher, writer, travel buff and now Espresso's Product Offerings Head. Ten years here has allowed me to lead the digital team at Sharekhan. My true passion lies in stock market charts.